2026 NPPES data Family Nurse Practitioner NPI 1497207575
Verify on CMS →

TAMARA CEPHAS

Family Nurse Practitioner in TULSA, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 417 beneficiaries · Family Nurse Practitioner avg: 1K
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.2403/100
▲ 8 pts above national avg 83.1 · [object Object]

What the federal data shows

TAMARA CEPHAS reported a CMS MIPS final score of 91.2403/100 — above the 83.1 national average — and filed 4,065 Medicare Part D claims in 2023.

91.2403/100
MIPS score · +8 vs avg
4K
Part D claims, 2023
77%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

TAMARA CEPHAS's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about TAMARA CEPHAS?

High performer (top quartile)

NPI registry status

Active

Issued 10/25/2016

NPI 1497207575

Primary specialty

Family Nurse Practitioner

High-volume

209,817 US NPIs in this specialty

Medicare Part D claims

4,065 233% vs specialty avg

2023 prescription claims

Specialty avg: 1,222

MIPS final score

91.2403/100 8.14030000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Oklahoma

How Family Nurse Practitioner compares to other specialties among Oklahoma providers

Oklahoma providers

Family Nurse Practitioner share within Oklahoma

1. Family Nurse Practitioner42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Family Nurse Practitioner share within Oklahoma

Medicare quality performance — MIPS

TAMARA CEPHAS's 2023 MIPS final score plotted against the Family Nurse Practitioner national average

High performer (top quartile)
MIPS Final Score
91.2403/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Family Nurse Practitioner) — 91.2403/100 vs national avg 83.1

0%100%National avg83%91.2%
MIPS final score (Family Nurse Practitioner) — 91.2403/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TAMARA CEPHAS appears in the CMS NPPES registry as a Family Nurse Practitioner provider at 1923 S UTICA AVE, TULSA, OK, 74104, with a listed phone of (918) 748-4650. NPI 1497207575 was issued on 10/25/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CEPHAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,065 prescription claims written by this provider, covering 417 Medicare beneficiaries and totaling roughly $789K in drug spend, split 23% brand-name and 77% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.2403/100 for the 2023 performance year (Quality 74.1347), compared with the national average of 83.1.

Family Nurse Practitioner is a high-volume specialty nationwide, with 209,817 enrolled providers across 56 states and an average of 1,222 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1923 S UTICA AVE
TULSA, OK 74104

Provider Details

NPI 1497207575
Specialty Family Nurse Practitioner
Gender Female
NPI Issued 10/25/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.2403
Final Score
Avg: 83.1
74.1347
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where TAMARA CEPHAS bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ST JOHN PHYSICIANS INC
TULSA, OK

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

TAMARA CEPHAS — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 4,065 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,065
Total Claims
$789K
Total Drug Cost
417
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,278
Total Day Supply
246,622
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$722K
Generic Drug Cost
$67K

Patient Demographics

Average Patient Age
75.4 years
Avg HCC Risk Score
2.23
Gender Split
48% female / 52% male
Age Distribution
<65: 40, 65-74: 155, 75-84: 151, 85+: 71

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What TAMARA CEPHAS prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Spironolactone
640
Furosemide
350
Metoprolol Succinate
341
Torsemide
320
Entresto
Sacubitril/Valsartan
298
Carvedilol
216
Atorvastatin Calcium
197
Eliquis
Apixaban
197
Jardiance
Empagliflozin
186
Losartan Potassium
131

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Family Nurse Practitioner Overview

How TAMARA CEPHAS fits within the Family Nurse Practitioner landscape nationally.

209,817
Family Nurse Practitioner Providers in US
56
States with Family Nurse Practitioner
1,222
Avg Claims per Provider

TAMARA CEPHAS's 4,065 claims are above the specialty average of 1,222.

Nearby Family Nurse Practitioner Providers in Oklahoma

Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as CEPHAS.

Compare Family Nurse Practitioner nationally: see state-by-state distribution →

Frequently Asked Questions

What is TAMARA CEPHAS's specialty?
TAMARA CEPHAS specializes in Family Nurse Practitioner and practices in TULSA, Oklahoma.
How much does TAMARA CEPHAS prescribe under Medicare Part D?
In 2023, TAMARA CEPHAS wrote 4,065 Medicare Part D claims totaling $789K in drug costs for 417 beneficiaries.
What is TAMARA CEPHAS's Medicare quality score?
TAMARA CEPHAS has a CMS MIPS Final Score of 91.2403/100 (Quality: 74.1347). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TAMARA CEPHAS located?
TAMARA CEPHAS is located at 1923 S UTICA AVE, TULSA, OK, 74104. Phone: (918) 748-4650.
What is TAMARA CEPHAS's NPI number?
TAMARA CEPHAS's National Provider Identifier (NPI) is 1497207575, issued on 10/25/2016.
Does TAMARA CEPHAS prescribe more brand-name or generic drugs?
TAMARA CEPHAS's prescribing is 23% brand-name and 77% generic drugs by claim count, with $722K in brand drug costs.
How many Family Nurse Practitioner providers are there in the US?
There are 209,817 Family Nurse Practitioner providers across 56 states in the US. The average Family Nurse Practitioner provider writes 1,222 Medicare Part D claims per year.
What drugs does TAMARA CEPHAS prescribe most often?
Based on 2023 Medicare Part D data, TAMARA CEPHAS's most frequently prescribed drugs include Spironolactone, Furosemide, Metoprolol Succinate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TAMARA CEPHAS accept Medicare?
TAMARA CEPHAS appears in CMS Medicare data with 4,065 Part D claims and 417 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TAMARA CEPHAS's credentials?
TAMARA CEPHAS's NPI is 1497207575. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology